Microchip Q2 Sales Jump 42% to $1.62B, Topping Guidance
Microchip reported fiscal Q2 2027 net sales of $1.622 billion, up 42.2% year over year and above guidance, with non-GAAP EPS of $0.97 beating consensus; the December quarter was guided flat to down.
- 01THE PRINT — Microchip reported fiscal Q2 2027 net sales of $1.622 billion, up 42.2% year over year and above guidance, with non-GAAP EPS of $0.97 beating the $0.94 consensus.
- 02THE GUIDE — December-quarter sales were guided to down 3% to up 1% sequentially, with $53 million of one-time revenue dropping out; a 45.5-cent quarterly dividend was declared.
- 03THE WATCHPOINT — Whether the PCIe Gen6 design-win momentum converts into data-center revenue, whether supply constraints bite into the order book, and whether the December quarter lands inside the guided range.
WHAT HAPPENEDWhat Happened
Microchip Technology reported second-quarter fiscal 2027 net sales of $1.622 billion on November 5, 2026, up 42.2% year over year from $1.14 billion and up 9.2% sequentially, above the high end of its own guidance range of $1.589 billion to $1.618 billion. GAAP net income was $373.6 million, or $0.68 per diluted share, against guidance of $0.53 to $0.54, with GAAP gross profit of 65.9% and operating income of $464.5 million. Non-GAAP earnings were $0.97 per diluted share, above the $0.91 to $0.95 guidance range and the $0.94 consensus, on non-GAAP operating income of $639.9 million.
The December quarter looks softer. Microchip guided net sales to a range of down 3% to up 1% sequentially, a midpoint of down 1%, and flagged that about $53 million of infrequent revenue in the September quarter will not repeat. The board declared a quarterly cash dividend of 45.5 cents per share, payable December 8, 2026 to holders of record on November 23, 2026. Design wins for PCIe Gen6 switches and retimers rose to 24 from 12 in the June quarter. Shares fell 13.9% in the regular session on November 5, before the results crossed after the close, in a broad selloff across semiconductor names.
WHY IT MATTERSA 42% recovery with a flat guide attached
The 42.2% year-over-year sales jump is the strongest print of Microchip's recovery from the distribution inventory correction, and a non-GAAP operating margin of 39.5% shows operating expenses growing well below sales. Beating the high end of guidance while topping the earnings consensus by three cents is a clean quarter on its own terms.
The guide is the other half. A December quarter guided to down 3% to up 1% sequentially, with $53 million of one-time revenue dropping out, reads as management refusing to extrapolate September's strength. The 13.9% session drop came before the release, so it was a verdict on the sector-wide selloff rather than on these numbers.
WHY IT MATTERSPCIe Gen6 design wins are the AI data-center tell
Design wins for PCIe Gen6 switches and retimers doubled to 24 from 12 in a single quarter, the clearest product signal in the release. Microchip's data-center portfolio, built for AI infrastructure demand, is where the recovery is supposed to compound, and design wins are the leading indicator that it is.
The risk is the one analysts flagged ahead of the print: foundry capacity constraints, longer lead times and rising manufacturing costs. A 42% growth quarter built on a recovering cycle can stall quickly if supply cannot keep up with the order book.
SIGNAL JUDGMENT — ANALYSISA strong recovery quarter, priced against a flat winter
Tokenta Signal's judgment: $1.622 billion, up 42%, with a 39.5% non-GAAP operating margin, is a genuine recovery print, and the PCIe Gen6 design-win doubling gives the AI data-center story something concrete. But a December guide of flat to down, with $53 million of one-time revenue falling away, means the recovery is not yet a straight line. The quarter earns the beat; the guide earns the caution.
WHAT REMAINS UNCERTAINWhat Remains Uncertain
EVIDENCEEvidence
Microchip Technology's official second-quarter fiscal 2027 results were published November 5, 2026 and read in full through a wire republication of the release: net sales $1.622 billion, up 42.2% year over year and 9.2% sequentially, above the high end of the $1.589-$1.618 billion guidance range; GAAP gross profit 65.9%, operating income $464.5 million, net income $373.6 million, EPS $0.68 per diluted share; non-GAAP EPS $0.97 per diluted share, non-GAAP operating income $639.9 million, a 39.5% margin; December-quarter net sales guided to down 3% to up 1% sequentially; about $53 million of infrequent revenue in the September quarter will not repeat; quarterly cash dividend of 45.5 cents declared, payable December 8, 2026; PCIe Gen6 switch and retimer design wins rose to 24 from 12 in the June quarter. A second independent report confirms the headline figures, and MarketBeat's consensus was revenue $1.61 billion and EPS $0.94. Shares fell 13.9% in the regular session on November 5, 2026, before the release crossed after the close.
PRIMARY SOURCESPrimary Sources
- Quantisnow: Microchip Technology Announces Financial Results for Second Quarter of Fiscal Year 2027
https://www.quantisnow.com/insight/microchip-technology-announces-financial-results-for-second-quarter-of-fiscal-6776608 - Seeking Alpha (via Feedcast): Microchip Technology Non-GAAP EPS of $0.97 beats by $0.03, revenue of $1.62B beats by $10M
https://www.feedcast.news/microchip-technology-non-gaap-eps-of-097-beats-by-003-revenue-of-162b-beats-by-qqrg45
RELATEDRelated Intelligence
- Oklo Posts First Revenue of $1.86M as Q3 Loss Widens to $41.7M, Liquidity Hits $3.13B
- Moderna Swings to $162M Profit as Q3 Revenue Hits $1.31B, Crushing Estimates
- Monster Q3 Sales Hit a Record $2.56B on International Growth, but Margins Squeeze Shares
- BILL Q1 Profit Beats, but an Accounting Change Makes Revenue Look Like a Miss